The lung transplant patient in the ICU

Current Opinion in Critical Care

Volumn 18, Issue 5, 2012, Pages 472-478

  Fuehner, Thomas ^a   Greer, Mark ^a   Welte, Tobias ^a   Gottlieb, Jens ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Chronic lung allograft syndrome; Infection; Lung transplantation; Primary graft dysfunction, rejection

Indexed keywords

ACUTE GRAFT REJECTION; INTENSIVE CARE UNIT; LONG TERM SURVIVAL; LUNG TRANSPLANTATION; PRIMARY GRAFT DYSFUNCTION; RESPIRATORY TRACT DISEASE; REVIEW; THROMBOTIC THROMBOCYTOPENIC PURPURA;

GRAFT REJECTION; HUMANS; INFECTION; INTENSIVE CARE UNITS; LUNG; LUNG TRANSPLANTATION; MYCOSES; PRIMARY GRAFT DYSFUNCTION; THROMBOTIC MICROANGIOPATHIES; TIME FACTORS;

EID: 84865981664     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e328356d982     Document Type: Review

References (63)

1. Lynch JP 3rd, Saggar R, Weigt SS, et al. Overview of lung transplantation and criteria for selection of candidates. Semin Respir Crit Care Med 2006; 27:441-469. (Pubitemid 44672549)
2. Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report -2011. J Heart Lung Transplant 2011; 30:1104-1122.
3. Gottlieb J. Update on lung transplantation. Ther Adv Respir Dis 2008; 2:237-247.
4. Meers C, Van Raemdonck D, Verleden GM, et al. The number of lung transplants can be safely doubled using extended criteria donors; a singlecenter review. Transpl Int 2010; 23:628-635.
5. Fuehner T, Kuehn C, Hadem J, et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med 2012; 185:763-768.
6. Gottlieb J, Warnecke G, Hadem J, et al. Outcome of critically ill lung transplant candidates on invasive respiratory support. Intensive Care Med 2012; 38:968-975.
7. Thabut G, Ravaud P, Christie JD, et al. Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177:1156-1163. (Pubitemid 351717576)
8. Christie JD, Bavaria JE, Palevsky HI, et al. Primary graft failure following lung transplantation. Chest 1998; 114:51-60. (Pubitemid 28337361)
9. Christie JD, Bellamy S, Ware LB, et al. Construct validity of the definition of primary graft dysfunction after lung transplantation. J Heart Lung Transplant 2010; 29:1231-1239.
10. Christie JD, Carby M, Bag R, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24:1454-1459. (Pubitemid 41396439)
11. Herrera JM, McNeil KD, Higgins RS, et al. Airway complications after lung transplantation: treatment and long-term outcome. Ann Thorac Surg 2001; 71:989-993. (Pubitemid 32210416)
12. Van De Wauwer WC, Van Raemdonck D, Verleden GM, et al. Risk factors for airway complications within the first year after lung transplantation. Eur J Cardiothorac Surg 2007; 31:703-710. (Pubitemid 46420421)
13. Gottlieb J, Fuehner T, Dierich M, et al. Are metallic stents really safe? A longterm analysis in lung transplant recipients. Eur Respir J 2009; 34:1417-1422.
14. Herrera JM, McNeil KD, Higgins RS, et al. Airway complications after lung transplantation: treatment and long-term outcome. Ann Thorac Surg 2001; 71:989-993. (Pubitemid 32210416)
15. Fuehner T, Dierich M, Duesberg C, et al. Endoscopic indicators for obstructive airway complications after lung transplantation. Transplantation 2010; 90:1210-1214.
16. Santacruz JF, Mehta AC. Airway complications and management after lung transplantation: ischemia, dehiscence, and stenosis. Proc Am Thorac Soc 2009; 6:79-93.
17. Kshettry VR, Kroshus TJ, Hertz MI, et al. Early and late complications after lung transplantation: incidence and management. Ann Thorac Surg 1997; 63:1576-1583. (Pubitemid 27321517)
18. Chhajed PN, Malouf MA, Glanville AR. Bronchoscopic dilatation in the management of benign (nontransplant) tracheobronchial stenosis. Intern Med J 2001; 31:512-516.
19. Abi-Jaoudeh N, Francois RJ, Oliva VL, et al. Endobronchial dilation for the management of bronchial stenosis in patients after lung transplantation: effect of stent placement on survival. J Vasc Interv Radiol 2009; 20:912-920.
20. Keller CA, Hinerman R, Singh A, et al. The use of endoscopic argon plasma coagulation in airway complications after solid organ transplantation. Chest 2001; 119:1968-1975. (Pubitemid 32744966)
21. Halkos ME, Godette KD, Lawrence EC, et al. High dose rate brachytherapy in the management of lung transplant airway stenosis. Ann Thorac Surg 2003; 76:381-384. (Pubitemid 36960573)
22. Carre P, Rousseau H, Lombart L, et al. Balloon dilatation and self-expanding metal Wallstent insertion. For management of bronchostenosis following lung transplantation. The Toulouse Lung Transplantation Group. Chest 1994; 105:343-348. (Pubitemid 24066695)
23. Lischke R, Pozniak J, Vondrys D, et al. Novel biodegradable stents in the treatment of bronchial stenosis after lung transplantation. Eur J Cardiothorac Surg 2011; 40:619-624.
24. Fuehner T, Simon A, Dierich M, et al. Indicators for steroid response in biopsy proven acute graft rejection after lung transplantation. Respir Med 2009; 103:1114-1121.
25. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26:1229-1242. (Pubitemid 350256994)
26. Morrell MR, Patterson GA, Trulock EP, et al. Acute antibody mediated rejection after lung transplantation. J Heart Lung Transplant 2009; 28:96-100.
27. Astor TL, Weill D, Cool C, et al. Pulmonary capillaritis in lung transplant recipients: treatment and effect on allograft function. J Heart Lung Transplant 2005; 24:2091-2097. (Pubitemid 41814730)
28. Sato M, Waddell TK, Wagnetz U, et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant 2011; 30:735-742.
29. Finlen Copeland CA, Snyder LD, Zaas DW, et al. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients. Am J Respir Crit Care Med 2010; 182:784-789.
30. Morrell MR, Despotis GJ, Lublin DM, et al. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2010; 29:424-431.
31. Gottlieb J, Szangolies J, Koehnlein T, et al. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2008; 85:36-41.
32. Verleden GM, Verleden SE, Vos R, et al. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study. Transpl Int 2011; 24:651-656.
33. Gottlieb J, Welte T, Hoper MM, et al. [Lung transplantation. Possibilities and limitations]. Internist (Berl) 2004, 45:1246-1259.
34. Fuehner T, Welte T, Gottlieb J. Lung transplantation. Internist (Berl) 2012; 53:567-574.
35. Roberts P, Follette D, Allen R, et al. Cyclosporine A-associated thrombotic thrombocytopenic purpura following lung transplantation. Transplant Proc 1998; 30:1512-1513. (Pubitemid 28309667)
36. Hachem RR, Yusen RD, Chakinala MM, et al. Thrombotic microangiopathy after lung transplantation. Transplantation 2006; 81:57-63. (Pubitemid 43122149)
37. Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Kidney Int 2001; 60:831-846. (Pubitemid 34205784)
38. Kotloff RM, Thabut G. Lung transplantation. Am J Respir Crit Care Med 2011; 184:159-171.
39. Aguilar-Guisado M, Givalda J, Ussetti P, et al. Pneumonia after lung transplantation in the RESITRA cohort: a multicenter prospective study. Am J Transplant 2007; 7:1989-1996. (Pubitemid 47037992)
40. Palmer SM, Limaye AP, Banks M, et al. Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial. Ann Intern Med 2010; 152:761-769.
41. Russo MJ, Sternberg DI, Hong KN, et al. Postlung transplant survival is equivalent regardless of cytomegaloviruss match status. Ann Thorac Surg 2007; 84:1129-1134.
42. Kotton CN, Kumar D, Caliendo AM, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010; 89:779-795.
43. Paya C, Humar A, Dominguez E, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004; 4:611-620. (Pubitemid 38523584)
44. Hodson EM, Craig JC, Strippoli GF, et al. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev 2008; CD003774.
45. Kumar D, Husain S, Chen MH, et al. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation 2010; 89:1028-1033.
46. Khalifah AP, Hachem RR, Chakinala MM, et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004; 170:181-187. (Pubitemid 38925165)
47. Hopkins P, McNeil K, Kermeen F, et al. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus. Am J Respir Crit Care Med 2008; 178:876-881.
48. Kumar D, Erdman D, Keshavjee S, et al. Clinical impact of community acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2005; 5:2031-2036. (Pubitemid 41039882)
49. Gottlieb J, Schulz TF, Welte T, et al. Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study. Transplantation 2009; 87:1530-1537.
50. Milstone AP, Brumble LM, Barnes J, et al. A single-season prospective study of respiratory viral infections in lung transplant recipients. Eur Respir J 2006; 28:131-137. (Pubitemid 44914270)
51. Ventre K, Randolph AG. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev 2007; CD000181.
52. Pelaez A, Lyon GM, Force SD, et al. Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection. J Heart Lung Transplant 2009; 28:67-71.
53. Fuehner T, Dierich M, Duesberg C, et al. Single-centre experience with oral ribavirin in lung transplant recipients with paramyxovirus infections. Antivir Ther 2011; 16:733-740.
54. Moran JJ, Rose WE, Darga AJ, et al. Persistence of influenza vaccine-induced antibodies in lung transplant patients between seasons. Transpl Infect Dis 2011; 13:466-470.
55. Manuel O, Humar A, Berutto C, et al. Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients. J Heart Lung Transplant 2011; 30:679-684.
56. Hayney MS, Welter DL, Francois M, et al. Influenza vaccine antibody responses in lung transplant recipients. Prog Transplant 2004; 14:346-351. (Pubitemid 40444189)
57. Neofytos D, Fishman JA, Horn D, et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis 2010; 12:220-229.
58. Hosseini-Moghaddam SM, Husain S. Fungi and molds following lung transplantation. Semin Respir Crit Care Med 2010; 31:222-233.
59. Meersseman W, Lagrou K, Maertens J, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008; 177:27-34.
60. Husain S, Kwak EJ, Obman A, et al. Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant 2004; 4:796-802. (Pubitemid 38637580)
61. Husain S, Paterson DL, Studer SM, et al. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 2007; 83:1330-1336. (Pubitemid 46800308)
62. Mehrad B, Paciocco G, Martinez FJ, et al. Spectrum of aspergillus infection in lung transplant recipients: case series and review of the literature. Chest 2001; 119:169-175. (Pubitemid 32150563)
63. Nunley DR, Gal AA, Vega JD, et al. Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation. Chest 2002; 122:1185-1191. (Pubitemid 35339528)